Roivant Sciences Ltd. (ROIV) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
the bull case· 2
+1.66%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '264
of the funds on file reporting a position in ROIV
n-portas of Jun 30 '26the bear case· 3
10 of 23
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '2633
managers whose positions together make up four fifths of the reported value
13fJun 30 '261.16%
of State Street SPDR S&P Biotech ETF's assets, the largest fund weight on file
n-portJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 12 '26 report. Not a forecast, not advice.
Of the 6 companies Roivant Sciences Ltd. moves with most closely, none share its SEC classification.
Measured against 501 trading days of our own closes. Co-movement, not cause.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
tall tick = annual report · 1 on record
497 managers report a position worth $20.4B between them, and 34 of them hold 80% of it.
ROIV (Roivant Sciences Ltd.) has 4 disclosed suppliers and 2 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
High 40.57 at 12:00 pm ET, low 39.77 at 9:45 am ET.
Roivant Sciences Ltd.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations